RJ
Robert T. Davis Jr.
EVP & President, TR&DT

Robert T. Davis Jr. insider trades: Integra Lifesciences Holdings (IART) stock sales

EVP & President, TR&DT, Integra Lifesciences Holdings Last trade Mar 6, 2024 40 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
5
Open-market trades
since 2016
1
Company
last trade 2024

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Robert reports to the SEC

Open-market buys and sales

5 trades reported on SEC Form 4, newest first

DateStockTypeValue
Mar 6, 2024IART↓ Sell$305K
Mar 1, 2023IART↓ Sell$86K
Feb 25, 2021IART↓ Sell$1.7M
Jul 24, 2019IART↓ Sell10b5-1$1.3M
Apr 29, 2016IART↓ Sell$105K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Robert T. Davis Jr.'s insider trades

Robert T. Davis Jr. is EVP & President, TR&DT at Integra Lifesciences Holdings (IART). Since Apr 29, 2016, Robert has reported no open-market purchases and 5 sales worth $3.6M on SEC Form 4. There have been no open-market trades in the last 12 months.

1 sale (37% of the value sold) was made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so it says little about how the insider sees the stock today.

Their filings also include grants and awards (26 filings), shares withheld for taxes (22 filings), option exercises (3 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every IART insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.